Xeljanz: Pfizer Says Fda Approves Arthritis Drug

NEW YORK -- Pfizer says the Food and Drug Administration approved its rheumatoid arthritis pill Xeljanz (ZEL'jans), seen as potential big seller for the world's largest pharmaceutical company.Pfizer Inc. says the FDA approved Xeljanz as a treatment for moderate to severe rheumatoid arthritis in patients who can't take methotrexate or haven't been helped by it.

Topics:  york    pfizer   food   drug administration   xeljanz zel'jans    pfizer inc   fda   video   xeljanz   arthritis   rheumatoid   approved   
BING NEWS:
  • FDA Approves Bimekizumab for Adults With Hidradenitis Suppurativa
    The US Food and Drug Administration has approved bimekizumab, a humanized interleukin (IL)-17A and IL-17F antagonist, for the treatment of adults with moderate to severe hidradenitis suppurativa (HS).
    11/20/2024 - 5:32 am | View Link
  • FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
    FDA approves UCB's Bimzelx for adults with moderate to severe hidradenitis suppurativa, supported by Phase 3 trials showing significant symptom improvement.
    11/20/2024 - 3:57 am | View Link
  • FDA Approves Bimekizumab in Hidradenitis Suppurativa
    This approval is the fifth overall for bimekizumab (Bimzelyx; UCB Pharma) in the US, and they all have come in the last 13 months.
    11/20/2024 - 2:34 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News